[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100533157":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":39,"collaborators":10,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":10,"eligibilityCriteria":46,"healthyVolunteers":43,"sex":47,"minAge":48,"maxAge":10,"enrollmentInfo":49,"targetDuration":10,"studyType":52,"phases":10,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Invivoscribe, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Residual Specimens",null,"Residual specimen\u002Fsample collection study where peripheral blood (PB), bone marrow (BM), genomic (gDNA), and\u002For formalin-fixed paraffin-embedded tissue (FFPE) specimens\u002Fsamples are obtained from patient samples sent to LabPMM, LLC for clinical testing.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Andrew Schut","CONTACT","+1 858.224.6600","aschut@invivoscribe.com",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"LabPMM","RECRUITING","San Diego","California","92121","United States","US",{"type":28,"coordinates":29},"Point",[30,31],-117.16472,32.71571,{"lat":31,"lon":30},[34,36],{"name":14,"role":15,"phone":35,"phoneExt":10,"email":17},"858-224-6600",{"name":37,"role":38,"phone":10,"phoneExt":10,"email":10},"Jordan Thornes","PRINCIPAL_INVESTIGATOR",{"type":40,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100533157","the-use-of-residual-de-identified-specimens-andor-samples-from-patients-for-clinical-research-100533157",false,"NCT06222164","The Use of Residual De-identified Specimens and\u002For Samples From Patients for Clinical Research","Inclusion Criteria:\n\n1. Specimen\u002Fsample, peripheral blood (PB), bone marrow (BM), genomic DNA (gDNA) and\u002For formalin-fixed paraffin-embedded tissue (FFPE) from patients whose specimens\u002Fsamples have been sent to LabPMM for clinical testing\n2. Donor Age ≥ 18 years\n\nExclusion Criteria:\n\n1. Sample\u002Fspecimen has been obtained from a third-party vendor with a Materials Transfer Agreement (MTA) on file with LabPMM\n2. The specimens\u002Fsamples have previously been enrolled in a clinical study","ALL","18 Years",{"count":50,"type":51},2000,"ESTIMATED","OBSERVATIONAL","Acquire residual human specimens and\u002For samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research",[55],"Hematologic Diseases",[57],"residual samples hematologic diseases","2025-05-02",{"date":60,"type":61},"2025-05-04","ACTUAL",{"date":63,"type":61},"2024-03-30",{"date":65,"type":51},"2027-06-30",{"name":5,"class":6},1]